← Leaderboards
Qing Kenneth Wang
Cleveland Clinic Foundation
$9,477,792
Attributed
$9,757,481
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$9,757,481 · 9
By mechanism
R01$9,748,594 · 7
P41$8,887 · 2
Top collaborators
- Qiuyun Chen1 shared
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationLeadPublic Health RelevanceGenesProteinsBaseGeneticArrhythmiaPathway InteractionsGene ExpressionMolecular GeneticsMolecularDisease /Disorder ModelPathogenesisChromosomesLaboratory MousePhenotypeAffectAreaFamilyComplexCoronary ArteriosclerosisKnockout MiceCells
Grant awards (24)
Targeting a novel AGGF1 signaling pathway for therapy of pulmonary hypertension$559,379
R01 · FY2019 · HL · contact PI
Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias$396,248
R01 · FY2018 · HL · contact PI
NGS in Large CAD Families: In-Depth Identification of Rare Risk Genomic Variants$707,607
R01 · FY2017 · HL · contact PI
Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias$396,248
R01 · FY2017 · HL · contact PI
NGS in Large CAD Families: In-Depth Identification of Rare Risk Genomic Variants$707,607
R01 · FY2016 · HL · contact PI
Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias$396,248
R01 · FY2016 · HL · contact PI
NGS in Large CAD Families: In-Depth Identification of Rare Risk Genomic Variants$696,993
R01 · FY2015 · HL · contact PI
Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias$396,248
R01 · FY2015 · HL · contact PI
NGS in Large CAD Families: In-Depth Identification of Rare Risk Genomic Variants$707,607
R01 · FY2014 · HL · contact PI
Novel Role of a Nucleoporin Gene in Atrial Fibrillation, the Most Common Cardiac$369,923
R01 · FY2013 · HL · contact PI
Novel Role of a Nucleoporin Gene in Atrial Fibrillation, the Most Common Cardiac$388,575
R01 · FY2012 · HL · contact PI
Novel Role of a Nucleoporin Gene in Atrial Fibrillation, the Most Common Cardiac$392,500
R01 · FY2011 · HL · contact PI
Novel Role of a Nucleoporin Gene in Atrial Fibrillation, the Most Common Cardiac$392,500
R01 · FY2010 · HL · contact PI
Molecular Mechanisms of Cardiac Arrhythmias$437,731
R01 · FY2005 · HL
PREMATURE MYOCARDIAL INFARCTION LOCUS ON CHROMOSOME 1P34-36$4,440
P41 · FY2005 · RR
Molecular Mechanisms of Cardiac Arrhythmias$425,034
R01 · FY2004 · HL
Molecular Determinants of Coronary Artery Disease$189,186
R01 · FY2004 · HL
CHROMOSOME 1 LOCUS FOR PREMATURE MYOCARDIAL INFARCTION$4,447
P41 · FY2004 · RR
Molecular Mechanisms of Cardiac Arrhythmias$412,710
R01 · FY2003 · HL
GENES FOR VASCULAR MORPHOGENESIS: A GENETIC APPROACH$330,165
R01 · FY2003 · HL
Molecular Mechanisms of Cardiac Arrhythmias$384,703
R01 · FY2002 · HL
GENES FOR VASCULAR MORPHOGENESIS: A GENETIC APPROACH$320,775
R01 · FY2002 · HL
GENES FOR VASCULAR MORPHOGENESIS: A GENETIC APPROACH$350,236
R01 · FY2001 · HL
GENES FOR VASCULAR MORPHOGENESIS: A GENETIC APPROACH$390,371
R01 · FY2000 · HL